<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-108627-003</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">A non-replicative adenovirus vaccine platform for poultry diseases</narrative>
   <narrative xml:lang="FR">Une plateforme pour la mise au point d&#x2019;un vaccin anti-ad&#xE9;novirus non r&#xE9;plicatif contre les maladies aviaires</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">La volaille constitue un &#xE9;levage de village essentiel et elle rev&#xEA;t une importance particuli&#xE8;re pour l&#x2019;ind&#xE9;pendance &#xE9;conomique des femmes en Afrique subsaharienne. En p&#xE9;riode de crise &#xE9;conomique, la volaille devient l&#x2019;&#xE9;levage essentiel en raison de sa polyvalence et de son ind&#xE9;pendance. La maladie de Newcastle (MN) est l&#x2019;une des maladies de la volaille les plus graves en Afrique subsaharienne, certains pays signalant en moyenne dix &#xE9;closions de MN par ann&#xE9;e. Les vaccins actuels contre la MN sont soit des virus de MN vivants ou des virus inactiv&#xE9;s. Les vaccins de MN inactiv&#xE9;s offrent une protection incompl&#xE8;te, alors que les vaccins vivants, m&#xEA;me s&#x2019;ils sont protecteurs, peuvent causer la maladie chez des oiseaux non infect&#xE9;s et non vaccin&#xE9;s. De plus, les vaccins de MN actuels sont produits dans des oeufs embryonn&#xE9;s de poulet exempts de pathog&#xE8;nes sp&#xE9;cifiques, lesquels sont dispendieux et inefficaces comme m&#xE9;thode de production de vaccins. Les vecteurs ad&#xE9;noviraux, qui sont largement utilis&#xE9;s pour les vaccins recombinants, pr&#xE9;sentent beaucoup d&#x2019;avantages, y compris une fabrication &#xE9;conomique, une stabilit&#xE9; &#xE0; long terme, une efficacit&#xE9; &#xE9;lev&#xE9;e et un profil d&#x2019;innocuit&#xE9; bien &#xE9;tabli aupr&#xE8;s des humains et des animaux. 

Le projet propos&#xE9; utilisera un vaccin anti-ad&#xE9;novirus non r&#xE9;plicatif afin d&#x2019;exprimer deux importants d&#xE9;terminants antig&#xE9;niques de protection contre la MN : la glycoprot&#xE9;ine HN et la prot&#xE9;ine F. Le vaccin de vecteur ad&#xE9;noviral recombinant sera produit dans un syst&#xE8;me de culture de cellules HEK293 plut&#xF4;t que dans des oeufs exempts de pathog&#xE8;nes sp&#xE9;cifiques. D&#xE9;velopper un vaccin de MN recombinant qui est s&#xE9;curitaire et efficace et qui profite d&#x2019;une production efficace am&#xE9;liorera la disponibilit&#xE9; et l&#x2019;abordabilit&#xE9; du vaccin de MN, offrant d&#x2019;importants avantages pour les petits exploitants de volaille en Afrique. Un deuxi&#xE8;me objectif de ce projet est de transf&#xE9;rer les capacit&#xE9;s techniques pour le d&#xE9;veloppement et la production des vaccins ad&#xE9;noviraux recombinants vers l&#x2019;&#xC9;thiopie. 

Ce projet est financ&#xE9; gr&#xE2;ce au Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB), un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Cet investissement conjoint de 57 millions CAD sur cinq ans permet de financer le d&#xE9;veloppement, la production et la commercialisation de vaccins innovants contre les maladies du b&#xE9;tail prioritaires en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-Est.</narrative>
   <narrative xml:lang="EN">Poultry are a vital village livestock asset and are particularly important for the economic independence of women in sub-Saharan Africa (SSA). In times of financial crisis, poultry become the most critical livestock asset due to their versatility and independence. Newcastle disease (ND) is one of the most critical poultry diseases in SSA, with some countries reporting on average ten ND outbreaks per year.  Current vaccines against ND are either live or inactivated ND viruses. Inactivated ND vaccines provide incomplete protection, while live vaccines, although protective, may cause disease in uninfected and unvaccinated birds. In addition, current ND vaccines are produced in specific pathogen-free (SPF) chicken embryonated eggs, which are expensive and inefficient as a vaccine production method. Adenovirus (Ads) vectors are extensively used for recombinant vaccines with many advantages, including cost-effective manufacturing, long-term stability, high efficacy, and a well-established safety profile in humans and animals. 

The proposed project will use a non-replicative adenovirus to express two major antigenic determinants of protection against ND: the glycoprotein HN and the F protein. The resultant recombinant adenovirus vectored vaccine will be produced in a HEK293 cell culture system rather than SPF eggs. Developing a recombinant ND vaccine that is safe and effective and which has the advantage of efficient production will enhance the availability and affordability of the ND vaccine with major gains for poultry smallholder farmers in Africa. A secondary aim of this project is to transfer technical capacity for recombinant adenovirus vaccine development and production to Ethiopia. 

This project is funded through the Livestock Vaccine Innovation Fund, a partnership between the Bill and Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
   <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="10">
   <narrative xml:lang="EN">National Veterinary Institute</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">National Veterinary Institute</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2017-12-15" type="2"></activity-date>
  <activity-date iso-date="2020-12-15" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-region code="289" percentage="100" vocabulary="1"></recipient-region>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="1" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-22"></transaction-date>
   <value currency="CAD" value-date="2018-02-22">174939.05</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-22"></transaction-date>
   <value currency="CAD" value-date="2018-02-22">90790.25</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-02-22"></transaction-date>
   <value currency="CAD" value-date="2018-02-22">65070.7</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-08"></transaction-date>
   <value currency="CAD" value-date="2018-03-08">13618</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-08"></transaction-date>
   <value currency="CAD" value-date="2018-03-08">26240</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-03-08"></transaction-date>
   <value currency="CAD" value-date="2018-03-08">9760</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-08-16"></transaction-date>
   <value currency="CAD" value-date="2018-08-16">15063</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-08-16"></transaction-date>
   <value currency="CAD" value-date="2018-08-16">21017</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-08-16"></transaction-date>
   <value currency="CAD" value-date="2018-08-16">40498</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-02-07"></transaction-date>
   <value currency="CAD" value-date="2019-02-07">16217</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-02-07"></transaction-date>
   <value currency="CAD" value-date="2019-02-07">22627</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-02-07"></transaction-date>
   <value currency="CAD" value-date="2019-02-07">43599</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-08-06"></transaction-date>
   <value currency="CAD" value-date="2019-08-06">16217</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-08-06"></transaction-date>
   <value currency="CAD" value-date="2019-08-06">22627</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-08-06"></transaction-date>
   <value currency="CAD" value-date="2019-08-06">43599</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-153938</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-57259</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">-79891</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">153938</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">57259</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="CAD" value-date="2020-03-31">79891</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">National Veterinary Institute</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
